Gene therapy trials
Executive Summary
Product characterization, pre-clinical models and long-term follow up issues related to gene therapy clinical trials will be discussed by FDA's Biological Response Modifiers Advisory Committee Nov. 16-17. The meeting will be held at the Holiday Inn in Bethesda, Md., beginning at 8:30 a.m